NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

維他命B6(吡哆醇)的全球市場(2021年∼2028年)

Global Vitamin B6 (Pyridoxine) Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1023077
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
維他命B6(吡哆醇)的全球市場(2021年∼2028年) Global Vitamin B6 (Pyridoxine) Market - 2021-2028
出版日期: 2021年08月12日內容資訊: 英文 180 Pages
簡介

由於健康上的優點強化了維他命B6的補充品的採用增加,帶動全球維他命B6(吡哆醇)市場成長。維他命B6用於吡哆醇缺乏症和貧血的預防、治療。還有憂鬱症,經前症候群(PMS),心臟病等也能使用。

本報告提供全球維他命B6(吡哆醇)市場的相關調查,市場規模,機會和影響,成長及阻礙因素,COVID-19的影響,各藥物類型、使用、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 維他命B6(吡哆醇)市場調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 維他命B6(吡哆醇)市場-市場定義和概要

第3章 維他命B6(吡哆醇)市場-摘要整理

  • 各藥物類型的市場明細
  • 各使用的市場明細
  • 各地區的市場明細

第4章 維他命B6(吡哆醇)市場動態

  • 影響市場的要素
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 維他命B6(吡哆醇)市場-產業分析

  • 波特的五力分析
  • 流行病學分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 維他命B6(吡哆醇)市場-COVID-19分析

  • 市場上的Covid-19分析
    • COVID-19前的市場方案
    • 目前市場方案
    • COVID-19後或今後方案
  • Covid-19的價格趨勢
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 維他命B6(吡哆醇)市場-各藥物類型

  • 簡介
    • 市場規模分析及與前一年同期比較成長分析
    • 市場魅力指數
  • 錠劑
  • 膠囊

第8章 維他命B6(吡哆醇)市場-各使用

  • 簡介
    • 市場規模分析及與前一年同期比較成長分析
    • 市場魅力指數
  • 更年期憂鬱症
  • 貧血

第9章 維他命B6(吡哆醇)市場-各地區

  • 簡介
    • 市場規模分析(2019-2028),及與前一年同期比較成長分析(2020-2028)
    • 市場魅力指數
  • 北美
    • 簡介
    • 各主要地區的動態
    • 各藥物類型:市場規模分析,及與前一年同期比較成長分析
    • 各使用:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 歐洲
    • 簡介
    • 各主要地區的動態
    • 各藥物類型:市場規模分析,及與前一年同期比較成長分析
    • 各使用:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 南美
    • 簡介
    • 各主要地區的動態
    • 各藥物類型:市場規模分析,及與前一年同期比較成長分析
    • 各使用:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 亞太地區
    • 簡介
    • 各主要地區的動態
    • 各藥物類型:市場規模分析,及與前一年同期比較成長分析
    • 各使用:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 中東和非洲
    • 簡介
    • 各主要地區的動態
    • 各藥物類型:市場規模分析,及與前一年同期比較成長分析
    • 各使用:市場規模分析,及與前一年同期比較成長分析

第10章 維他命B6(吡哆醇)市場-競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準
  • 值得注意的主要企業
  • 顛覆性技術的企業
  • Start-Ups企業

第11章 維他命B6(吡哆醇)市場-企業簡介

  • Teva pharmaceuticals
    • 企業概要
    • 產品系列、概要
    • 要點
    • 財務概要
  • Royal DSM N.V.
  • Jiangxi Tianxin Pharmaceutical Co. Ltd.
  • BASF SE
  • Huazhong Pharmaceutical
  • Acebright Pharmaceuticals Group
  • CordenPharma Farchemia
  • Tongji Pharmaceutical
  • Wuyao Pharmaceutical
  • API Polpharma

第12章 維他命B6(吡哆醇)市場-DataM

  • 附錄
  • 關於本公司、服務
  • 諮詢方式

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMPH3867

Vitamin B6 (Pyridoxine) Market Overview

The vitamin B6 (Pyridoxine) market size was valued at US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

For prevention and treatment of low levels of pyridoxine (pyridoxine deficiency) and the anemia vitamin B6 is used. It is also used for depression, premenstrual syndrome (PMS), heart disease and many other conditions.

Vitamin B6 (Pyridoxine) Market Dynamics

Increasing the adoption of vitamin B6 enriched supplements due to their health benefits will drive the market. Demand for vitamin-enriched food and beverages is increasing and will drive the Vitamin B6 (Pyridoxine) Market

Increasing adoption of vitamin B6 enriched supplements due to their health benefits will drive the market

Vitamin B6 is naturally present in many foods, is a water-soluble vitamin and available as a dietary supplement. This vitamin in coenzyme performs a wide variety of functions in the body and is extremely versatile, involving more than 100 enzyme reactions, mostly concerned with protein metabolism. Both PMP and PLP are involved in amino acid metabolism, and PLP is also involved in the metabolism of one-carbon units, lipids and carbohydrates. It also plays a role in cognitive development through the biosynthesis of neurotransmitters and maintains normal levels of homocysteine, an amino acid in the blood. Vitamin B6 is involved in glycogenolysis and gluconeogenesis, immune function (for example, it promotes lymphocyte and interleukin-2 production), and hemoglobin formation.

Vitamin B6 has been widely known for its role in prevention of disease. This in supplement form is most promising for the treatment of pregnancy-induced nausea, but such use should be occurred under the supervision of a physician. Adequate blood levels of B6 may be associated with a lower risk of cancers than low blood levels. However, the use of separate B6 supplements (apart from the RDA amounts in typical multivitamin preparations) is inconclusive and not recommended.

Demand for vitamin-enriched food and beverages is increasing and will drive the vitamin B6 (Pyridoxine) market

Worldwide, more than 2 billion people have micronutrient deficiencies because of insufficient essential minerals and vitamins each day. Food fortification through adding essential minerals and vitamins has been noted to be one of the most cost-effective, fastest and efficient methods used to increase the nutritional value of food products. Consumer awareness of the risk and prevalence of nutrient deficiencies (especially in iron, folic acid, vitamin A, iodine, and zinc) continues to grow, along with the understanding that these deficiencies can be easily corrected through supplementation.

Vitamin B6 is a co-factor in the formation of 帤-aminolevulinic acid, a rate-limiting step in heme biosynthesis. Vitamin B6 also plays a potentially important role in the incorporation of iron into protoporphyrin, the final step in heme synthesis. Hence, vitamin B6 is an important nutrient for erythropoiesis.

Stringent rules and regulations imposed on Pyridoxine will hamper the vitamin B6 (Pyridoxine) market

Only two drugs which are approved by FDA containing pyridoxine or its analogs are present. The first is a combination of many vitamins, including B6, indicated for the prevention of vitamin deficiency in adult and pediatric patients receiving parenteral nutrition and the other one is a combination of pyridoxine hydrochloride (a vitamin B6 analog) and doxylamine succinate for treatment of nausea and vomiting of pregnancy in oral tablet form that does not respond to conservative management.

Research shows conflicting results regarding the use of vitamin B6 supplements in treating premenstrual syndrome, gestational diabetes, carpal tunnel syndrome, morning sickness and treating and preventing essential hypertension. Even though scant evidence regarding pyridoxine's efficacy exists regarding these uses, it has been used empirically to treat some conditions, including atopic dermatitis, dental caries, acute alcohol intoxication, autism, diabetic complications, Down syndrome, schizophrenia, Huntington chorea and steroid-dependent asthma. The only two contraindications for vitamin B6 are hypervitaminosis B6, as toxic levels may cause sensory neuropathy and hypersensitivity to pyridoxine. Vitamin B6 can be toxic if its concentration in the body is too high, causing sensory neuropathy, whose mechanism is unknown. Research on the subject found that the duration of administration of the vitamin is directly proportional to the risk of clinically evident toxicity with respect to the total dose given.

COVID-19 Impact Analysis

COVID-19 has affected the healthcare industry. To curb its growth, government-imposed lockdown. People are fearful they will experience occupational effects and adverse health from the COVID-19 pandemic. This affects the vitamin B6 (Pyridoxine) market as many pharmaceutical industries have stopped manufacturing units.

Vitamin B6 (Pyridoxine) Market Segment Analysis

Tablet's segment will dominate the vitamin B6 (Pyridoxine) Market

Tablets are solid dosage forms consisting of the active ingredient and suitable pharmaceutical excipients. They are easy to carry, easy to swallow. They are attractive and easy to self-administration. Tablet does not require any measurement of dose.

In people with insufficient vitamins in their diets, pyridoxine (vitamin B6) is used to prevent or treat low levels of vitamin B6. Most of them who eat a normal diet do not need extra vitamin B6. However, some conditions (such as liver disease, overactive thyroid,alcoholism, heart failure) or medications (such as cycloserine, hydralazine, isoniazid, penicillamine) can cause low levels of vitamin B6. Vitamin B6 plays an important role in the body. It is needed to maintain the health of nerves, skin, and red blood cells. Pyridoxine has been used to prevent or treat a certain nerve disorder (peripheral neuropathy) caused by certain medications (such as isoniazid). It has also been used to treat certain hereditary disorders (xanthurenic aciduria, hyperoxaluria, homocystinuria). Pyridoxine is available under the following different brand names vitamin B6 and Nestrex.

The menopausal depression segment will dominate the vitamin B6 (Pyridoxine) market in the forecast period

Vitamin B-6 (pyridoxine) helps in making a chemical responsible for transmitting brain signals known as serotonin. Serotonin levels drop as women age such fluctuating serotonin levels may be a contributing factor in the depression and mood swings common in menopause. The hormonal havoc of menopause added to other common midlife changes, such as a decline in energy production and decreased body ability to absorb nutrients, can make menopause more challenging. The first step to regain physical and emotional balance is to take a diet which is rich in foods with high vitamin B6 and will also provide other important nutrients.

The RDA of vitamin B-6 is 100 milligrams (mg) daily for females 19 and older. Taking a vitamin B-6 supplement during and after menopause may help prevent symptoms caused by low serotonin levels. These include loss of energy and depression. Research shows that taking 50-80 mg of B6 supplements daily may help with symptoms of premenstrual syndrome (PMS), such as moodiness, irritability, anxiety and depression.

Vitamin B6 (Pyridoxine) Market Geographical Analysis

North America region will dominate the vitamin B6 (Pyridoxine) market

With increased research and development activity, the deficiency of vitamin B6, and major key players' presence, this region will dominate the Vitamin B6 (Pyridoxine) Market

According to U.S. Food and Drug Administration (FDA), About 28 percent to 36 percent of the normal population uses food supplements that contain vitamin B6 (pyridoxine). According to the National Institutes of Health (NIH), vitamin B6 deficiency is rare in the United States, but it can cause anemia, similar to iron deficiency anemia. In the US National Health and Nutrition Examination Survey (NHANES), over 40% of young adult women (21-44 years) had B6 deficiency (defined as having plasma PLP concentration < 20 nmol/L.

Vitamin B6 (Pyridoxine) Market Competitive Landscape

Teva pharmaceutical, Royal DSM N.V., Jiangxi Tianxin Pharmaceutical Co. Ltd., BASF SE, Huazhong Pharmaceutical, Acebright Pharmaceuticals Group, Now Foods, Shanghai Hegno Pharmaceutical Holding Co., Ltd., and Nanjing Pharmaceutical Factory Co. Ltd.

Vitamin B6 (Pyridoxine) Market Key Companies to Watch

Teva pharmaceuticals

Overview: For more than a century Teva Pharmaceuticals has been developing and producing medicines to help improve people's lives. They are global leaders commited in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Every day approximately 200 million people around the world take Teva medicine. They are served by one of the most complex and largest supply chains in the pharmaceutical industry.

Product Portfolio: The company is engaged in manufacturing generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology.

Key Development: Teva has released pyridoxine hydrochloride and doxylamine succinate delayed-release tablets in strength of 10 mg respectively. The drug, a generic version of Duchesnay's Diclegis is used to treat vomiting and nausea associated with pregnancy in women who have not improved with a diet change or other nonmedical treatments. The drug is available in bottles of 100 tablets.

Why Purchase the Report?

  • Visualize the composition of the vitamin B6 (Pyridoxine) market segmentation By Drug Type and by use highlighting the key commercial assets and players.
  • Identify commercial opportunities in vitamin B6 (Pyridoxine) market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of vitamin B6 (Pyridoxine) market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The vitamin B6 (Pyridoxine) market report would provide an access to an approx. 53 market data table, 45 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Vitamin B6 (Pyridoxine) Market- By Drug Type

  • Tablets
  • Capsules
  • Syrup
  • Others

Vitamin B6 (Pyridoxine) Market- By Use

  • Menopausal depression
  • Anaemia
  • Muscular Cramps
  • Fatigue
  • Others

Vitamin B6 (Pyridoxine) Market- By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Vitamin B6 (Pyridoxine) Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Vitamin B6 (Pyridoxine) Market- Market Definition and Overview

3. Vitamin B6 (Pyridoxine) Market- Executive Summary

  • 3.1. Market Snippet By Drug Type
  • 3.2. Market Snippet By Use
  • 3.3. Market Snippet By Region

4. Vitamin B6 (Pyridoxine) Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing adoption of vitamin B6 enriched supplements due to their health benefits will drive the market
      • 4.1.1.2. Demand for vitamin-enriched food and beverages is increasing and will drive the vitamin B6 (Pyridoxine) market
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent rules and regulations imposed on Pyridoxine will hamper the vitamin B6 (Pyridoxine) market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Vitamin B6 (Pyridoxine) Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Vitamin B6 (Pyridoxine) Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Vitamin B6 (Pyridoxine) Market- By Drug Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type Segment
    • 7.1.2. Market Attractiveness Index, By Drug Type Segment
  • 7.2. Tablets *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Capsules

8. Vitamin B6 (Pyridoxine) Market- By Use

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Use Segment
    • 8.1.2. Market Attractiveness Index, By Use Segment
  • 8.2. Menopausal depressions *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. ANAEMIA

9. Vitamin B6 (Pyridoxine) Market- By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Use
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Use
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Use
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Use
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Use

10. Vitamin B6 (Pyridoxine) Market- Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking
  • 10.4. Key Companies to Watch
  • 10.5. Company with disruptive technology
  • 10.6. Start Up Companies

11. Vitamin B6 (Pyridoxine) Market- Company Profiles

  • 11.1. Teva pharmaceuticals*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Royal DSM N.V.
  • 11.3. Jiangxi Tianxin Pharmaceutical Co. Ltd.
  • 11.4. BASF SE
  • 11.5. Huazhong Pharmaceutical
  • 11.6. Acebright Pharmaceuticals Group
  • 11.7. CordenPharma Farchemia
  • 11.8. Tongji Pharmaceutical
  • 11.9. Wuyao Pharmaceutical
  • 11.10. API Polpharma

LIST NOT EXHAUSTIVE

12. Vitamin B6 (Pyridoxine) Market- DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us